Related Experiment Video
Updated: Jun 1, 2026
04:08
Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes
Published on: June 27, 2025
[Misoprostol teratogenicity: a prospective study in Argentina]
Pablo Barbero1, Rosa Liascovich, Rita Valdez
1Centro Nacional de Genética Médica, ANLIS, Ministerio de Salud, Argentina. pablobarbero63@hotmail.com
Archivos Argentinos De Pediatria
|June 11, 2011
Summary
Prenatal exposure to misoprostol, commonly used for attempted abortion in Argentina, is linked to a higher risk of major congenital anomalies in offspring. This study highlights the potential teratogenic effects of misoprostol when used during pregnancy.
Area of Science:
- Obstetrics and Gynecology
- Teratology
- Pharmacovigilance
Context:
- Misoprostol is frequently used in Argentina for self-induced abortions.
- A significant proportion of pregnancies exposed to misoprostol are not interrupted.
- Previous reports suggest a link between misoprostol and congenital anomalies.
Purpose:
- To quantify the risk of major congenital anomalies in infants exposed to misoprostol prenatally.
- To investigate the patterns of misoprostol consumption during pregnancy.
Summary:
- A cohort study compared 94 women exposed to misoprostol with 401 unexposed pregnant women.
- Misoprostol-exposed pregnancies showed higher rates of abortion (18.1%) and major congenital anomalies (6.49%) compared to controls.
- Commonly used orally/vaginally at a mean dose of 1,439 μg, often without prescription and with additional abortifacients.
Impact:
- The findings indicate a significant association between prenatal misoprostol exposure and major congenital anomalies.
- This research underscores the teratogenic potential of misoprostol.
- Results inform counseling for pregnant individuals and highlight the need for safer abortion alternatives.
Related Concept Videos
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...